Phase 4 N=6 Lofexidine for Adults Undergoing Lumbar Spine Surgery
Opioid Withdrawal
Primary: Opioid Tapering — 5 Participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 1 N=56 This Study Tests the Safety, Tolerability and How Different Doses of BI 1265162 Are Taken up in the Body of Healthy Men
Healthy
Primary: Percentage of Participants With Drug-related Adverse Events (AEs) — 0; 0; 0; 16.7 Percentage of participants (%)
Phase 2 N=14 The Role of Aldosterone on Augmented Exercise Pressor Reflex in Hypertension
Hypertension
Primary: Muscle Sympathetic Nerve Activity at Rest — 41; 43.8 bursts/minute
Phase 1 N=25 A Study of Single Doses of Frespaciguat (MK-5475) on Pulmonary Vascular Resistance (MK-5475-002)
Pulmonary Arterial Hypertension
Primary: Number of Participants Who Experienced at Least 1 Adverse Event (AE): All Parts — 2; 1; 3; 5 Participants
Phase 3 N=2,014 Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy
Breast Ductal Carcinoma In Situ
Primary: Ipsilateral Invasive Breast Cancer, Ipsilateral Skin Cancer Recurrence, or Ipsilateral DCIS-Free Survival — 95.1; 96.1 percentage of patients event free
N/A N=130 Removal of the Evolution® Esophageal Stent - Fully Covered
Esophageal Fistula · Esophageal Neoplasms · Esophageal Perforation
Primary: Number of Patients With Successful Removal of Study Stent — 57 Participants
N/A N=306 SToRytelling to Improve DiseasE Outcomes in GOut: The STRIDE-GO2 Study
Gout · Low Medication Adherence · Health Related Quality of Life
Primary: Medication Adherence — 72.61; 70.12; 68.52; 69.33 percentage of days ULT was taken
N/A N=57 Magnetic Resonance Imaging (MRI) Brachytherapy Applicator Study
Cervical Cancer
Primary: Number of Participants With Improved Image Quality in the Shifted Position — 0; 15 Participants
Phase 3 N=215 Study to Evaluate the Efficacy and Safety of Risperidone ISM® in Patients With Acute Schizophrenia: Open Label Extension
Schizophrenia
Primary: PANSS Total Score Mean Change From Baseline to Endpoint — -22.9; -11.0; -0.8; -18.9 units on a scale
N/A N=53 physicAl aCtiviTy In minOrity womeN With Asthma Intervention
Asthma
Primary: Feasibility of Intervention-Recruitment — 53 participants
Phase 3 N=144 A Comparison of Bimatoprost SR to Selective Laser Trabeculoplasty in Patients With Open-Angle Glaucoma or Ocular Hypertension
Glaucoma · Open-Angle Ocular Hypertension
Primary: Intraocular Pressure (IOP) at Baseline — 24.45; 24.38 millimeters of mercury (mmHg)
Phase 4 N=60 Study Comparing Prandial Insulin Aspart vs. Technosphere Insulin in Patients With Type 1 Diabetes on Multiple Daily Injections: Investigator-Initiated A Real-life Pilot Study-STAT Study
Diabetes Mellitus, Type 1
Primary: Change in Time in Range (%) (70-180 mg/dl) With TI on CGM — 53.5; 58.4 percent time in range
Phase 3 N=153 Real World CCH Study in Adult Females With Cellulite
Edematous Fibrosclerotic Panniculopathy (EFP) · Cellulite
Primary: The Proportion of Participants With Improved (+1 or Better) Score on I-GAIS for Either Posterolateral Thigh — 58 Participants
Phase 4 N=20 Antiretroviral Therapy (ART) Persistence in Different Body Compartments in HIV Negative MSM
ART · HIV
Primary: Median Drug Levels in Plasma — 0; 0; 0; 0 ng/mL
Phase 2 N=62 Non-Invasive Diagnosis of Pulmonary Vascular Disease Using Inhaled 129Xe Magnetic Resonance Imaging
Pulmonary Vascular Disease
Primary: Participants Determined to be True Positives for Pulmonary Arterial Hypertension — 10; 15; 10; 5 Participants